MétaCan
Menu
← Back to cohort
Record W2898129267 · doi:10.1093/annonc/mdy297.022

How advanced lung cancer patients are really treated at the population level? The Ontario, Canada experience

2018· article· en· W2898129267 on OpenAlexaffabout
William K. Evans, W. Michael Flanagan, Cindy L. Gauvreau, Phongsack Manivong, S. Memon, Natalie Fitzgerald, John R. Goffin, Rochelle Garner, Edwin Khoo, Nicole Mittmann

Bibliographic record

VenueAnnals of Oncology · 2018
Typearticle
Languageen
FieldMedicine
TopicLung Cancer Diagnosis and Treatment
Canadian institutionsJuravinski Cancer CentreCancer Care OntarioCanadian Partnership Against CancerStatistics CanadaMcMaster University
Fundersnot available
KeywordsMedicineRadiation therapyStage (stratigraphy)Lung cancerCancer registryClinical trialCancerPopulationCohortInternal medicineSurgeryOncology

Abstract

fetched live from OpenAlex

Background: Clinical trials define treatment recommendations but patients in the real world may be unable or unwilling to undergo treatments with demonstrated efficacy in fit patients. The Canadian Partnership Against Cancer has developed a model of lung cancer (LC) management (OncoSim-lung) in 2008 based on clinical trials data and expert advice. To credibly project the future clinical and economic impacts of cancer control measures using OncoSim, the model has been refined using real-world data. Methods: Treatment data by histology and stage were extracted from the Ontario Cancer Registry for LC cohorts diagnosed in 2010 and 2013. All incident cases that satisfied the IARC rule of a new primary were included. Missing or unknown stage cases were excluded. Clinical pathways were validated by oncologists from different disciplines across Canada. Results: The 2013 cohort included 8,086 staged LC: NSCLC (n = 7,143) Stage I 18.7%, II 8%, III/IIIa 11.4%, IIIb 4.9% IV 56.8%; SCLC (n = 943) limited 67.7%, extensive 32.3%. Of 813 stage III/IIIa patients, only 26% underwent surgery, 41% of whom received adjuvant chemotherapy or postoperative radical radiotherapy (16%); 13% received trimodality treatment. Of the 75% of Stage III not receiving surgery, 26% had NAT and 21% had palliative radiotherapy alone. Of those receiving active treatment, 20% received combined chemo +radiotherapy and 13% each had chemotherapy alone or radical radiotherapy alone. Of 356 stage IIIb patients, 17% had NAT, 28% received palliative radiotherapy and only 30% had chemo + radical radiotherapy. 18% had chemo alone. Of 4055 stage IV NSCLC, 47% had NAT, 24% received chemotherapy alone and 23% had palliative radiotherapy only. Of those who received first-line chemotherapy (n = 1059), 47% received second line chemotherapy and of those, 37% received third line therapy. Conclusions: Compared to prior expert opinion, there was a much lower frequency of chemo-radiotherapy in Stage III disease and a higher frequency of NAT across all stages of disease. The updated OncoSim model will now have a credible real-world base from which the impacts of new treatment interventions on survival and budget impact can be better estimated. Legal entity responsible for the study: Canadian Partnership Against Cancer. Funding: Canadian Partnership Against Cancer. Disclosure: All authors have declared no conflicts of interest.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.121
Threshold uncertainty score0.881

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.010
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.004
Science and technology studies0.0050.002
Scholarly communication0.0030.001
Open science0.0010.002
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.369
Teacher spread0.313 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueAnnals of Oncology→Same topicLung Cancer Diagnosis and Treatment→French-language works237,207→